Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

A comparative analysis of in vitro and in vivo efficacies of the enantiomers of thioridazine and its racemate.

Christensen JB, Hendricks O, Chaki S, Mukherjee S, Das A, Pal TK, Dastidar SG, Kristiansen JE.

PLoS One. 2013;8(3):e57493. doi: 10.1371/journal.pone.0057493. Epub 2013 Mar 7.

2.

Potentiality of tricyclic compound thioridazine as an effective antibacterial and antiplasmid agent.

Radhakrishnan V, Ganguly K, Ganguly M, Dastidar SG, Chakrabarty AN.

Indian J Exp Biol. 1999 Jul;37(7):671-5.

PMID:
10522156
3.

Synthesis and antibacterial activity of novel oxazolidinones bearing N-hydroxyacetamidine substituent.

Takhi M, Murugan C, Munikumar M, Bhaskarreddy KM, Singh G, Sreenivas K, Sitaramkumar M, Selvakumar N, Das J, Trehan S, Iqbal J.

Bioorg Med Chem Lett. 2006 May 1;16(9):2391-5. Epub 2006 Feb 20.

PMID:
16488606
4.

In vitro and in vivo antibacterial activities of GV129606, a new broad-spectrum trinem.

Di Modugno E, Broggio R, Erbetti I, Lowther J.

Antimicrob Agents Chemother. 1997 Dec;41(12):2742-8.

5.

Reversal of resistance in microorganisms by help of non-antibiotics.

Kristiansen JE, Hendricks O, Delvin T, Butterworth TS, Aagaard L, Christensen JB, Flores VC, Keyzer H.

J Antimicrob Chemother. 2007 Jun;59(6):1271-9. Epub 2007 Apr 2. Review.

PMID:
17403708
6.

In-vitro and in-vivo activity of DWC-751, a new cephalosporin.

Choi KH, Kim DJ, Shim JS, Choi MJ, Park NJ, Kim BO, Yu YH, Choi EC.

J Antimicrob Chemother. 1994 Jun;33(6):1233-7. No abstract available. Erratum in: J Antimicrob Chemother 1995 Apr;35(4):561.

PMID:
7646611
7.

Thioridazine: resurrection as an antimicrobial agent?

Thanacoody HK.

Br J Clin Pharmacol. 2007 Nov;64(5):566-74. Epub 2007 Aug 31. Review.

8.

In vitro and in vivo activities of DW-224a, a novel fluoroquinolone antibiotic agent.

Kwon AR, Min YH, Ryu JM, Choi DR, Shim MJ, Choi EC.

J Antimicrob Chemother. 2006 Sep;58(3):684-8. Epub 2006 Jul 27.

PMID:
16873394
9.

Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens.

Hirokawa Y, Kinoshita H, Tanaka T, Nakata K, Kitadai N, Fujimoto K, Kashimoto S, Kojima T, Kato S.

J Med Chem. 2008 Apr 10;51(7):1991-4. doi: 10.1021/jm8000136. Epub 2008 Mar 11.

PMID:
18330977
10.
11.

Antibacterial activity of the antiinflammatory agent diclofenac sodium.

Annadurai S, Basu S, Ray S, Dastidar SG, Chakrabarty AN.

Indian J Exp Biol. 1998 Jan;36(1):86-90.

PMID:
9536657
12.

Novel carbapenem antibiotics for parenteral and oral applications: in vitro and in vivo activities of 2-aryl carbapenems and their pharmacokinetics in laboratory animals.

Fujimoto K, Takemoto K, Hatano K, Nakai T, Terashita S, Matsumoto M, Eriguchi Y, Eguchi K, Shimizudani T, Sato K, Kanazawa K, Sunagawa M, Ueda Y.

Antimicrob Agents Chemother. 2013 Feb;57(2):697-707. doi: 10.1128/AAC.01051-12. Epub 2012 Nov 12.

13.

In vitro and in vivo antibacterial activities of SM-216601, a new broad-spectrum parenteral carbapenem.

Ueda Y, Kanazawa K, Eguchi K, Takemoto K, Eriguchi Y, Sunagawa M.

Antimicrob Agents Chemother. 2005 Oct;49(10):4185-96.

14.

Comparative in-vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria.

Shibl AM, Ishag AH, Durgham SM.

J Chemother. 1989 Jul;1(4 Suppl):359-61. No abstract available.

PMID:
16312439
15.

Pyridone methylsulfone hydroxamate LpxC inhibitors for the treatment of serious gram-negative infections.

Montgomery JI, Brown MF, Reilly U, Price LM, Abramite JA, Arcari J, Barham R, Che Y, Chen JM, Chung SW, Collantes EM, Desbonnet C, Doroski M, Doty J, Engtrakul JJ, Harris TM, Huband M, Knafels JD, Leach KL, Liu S, Marfat A, McAllister L, McElroy E, Menard CA, Mitton-Fry M, Mullins L, Noe MC, O'Donnell J, Oliver R, Penzien J, Plummer M, Shanmugasundaram V, Thoma C, Tomaras AP, Uccello DP, Vaz A, Wishka DG.

J Med Chem. 2012 Feb 23;55(4):1662-70. doi: 10.1021/jm2014875. Epub 2012 Feb 8.

PMID:
22257165
16.

Combating evolution with intelligent design: the neoglycoside ACHN-490.

Armstrong ES, Miller GH.

Curr Opin Microbiol. 2010 Oct;13(5):565-73. doi: 10.1016/j.mib.2010.09.004. Review.

PMID:
20932796
17.
18.
19.

Studies on the antibacterial potentiality of isoflavones.

Dastidar SG, Manna A, Kumar KA, Mazumdar K, Dutta NK, Chakrabarty AN, Motohashi N, Shirataki Y.

Int J Antimicrob Agents. 2004 Jan;23(1):99-102.

PMID:
14732323
20.

Synthesis and in vitro activity of a series 1beta-methylcarbapenem derivatives.

Jeon HC, Kim JW, Hong JH, Cho JH, Oh CH.

Eur J Med Chem. 2006 Oct;41(10):1201-9. Epub 2006 Jun 22.

PMID:
16797791

Supplemental Content

Support Center